| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Revenue | $7.70B | +4.2% |
| Cost of Revenue | $6.82B | +4.3% |
| R&D Expense | $1.0M | -75.0% |
| SG&A Expense | $374.0M | +8.7% |
| Operating Income | $501.0M | +8.4% |
| Interest Expense | $120.0M | +14.3% |
| Pre-tax Income | $375.0M | +4.7% |
| Income Tax | $72.0M | -8.9% |
| Net Income | $300.0M |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Cash & Equivalents | $109.0M | +2.8% |
| Accounts Receivable | $936.0M | -7.8% |
| Inventory | $71.0M | +10.9% |
| Current Assets | $1.20B | -5.2% |
| Total Assets | $5.54B | -3.5% |
| Current Liabilities | $1.13B | -16.7% |
| Long-term Debt | $2.37B | -5.7% |
| Line Item | 2023-02-03 | Y/Y |
|---|---|---|
| Operating Cash Flow | $532.0M | +2.7% |
| Capital Expenditures | $25.0M | -30.6% |
| Investing Cash Flow | -$36.0M | +87.7% |
| Financing Cash Flow | -$493.0M | -63.8% |
| Free Cash Flow | $507.0M | +5.2% |
| +8.3% |
| EPS (Basic) | $5.42 | +12.7% |
| EPS (Diluted) | $5.38 | +12.8% |
| Stockholders' Equity |
| $1.69B |
| +4.6% |